Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) today. The company’s shares closed ...

CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...

Brian Newman will guide CVS’ finances at a challenging time for the retail pharmacy and health insurance giant. Still, CVS ...

(Reuters) - Elon Musk’s X has reached an agreement to resolve claims that live streaming service Twitch conspired with other ...

However, some stocks have survived a recent market rout as worries over a trade war escalate. Centene and Molina Healthcare ...

(Reuters) -CVS Health Corp Chief Financial Officer Thomas Cowhey intends to step down from his position, Bloomberg News ...